{"entity":{"type":"insider","cik":"0001559565","url":"/insider/0001559565","json_url":"/insider/0001559565.json","name":"Sofinnova Management VIII, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2014-03-28","last":"2018-09-20","span_basis":"filed_date"},"name_variants":[{"name":"Sofinnova Management VIII, L.L.C.","source":"filing","n_filings":5,"first_seen":"2014-03-28","last_seen":"2018-09-20"}],"transactions":[{"id":6707789,"accession":"0001209191-18-051838","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-051838","line_url":"/filing/0001209191-18-051838#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; HEALY JAMES; Sofinnova Management VIII, L.L.C.; Mehra Anand; Sofinnova Venture Partners VIII, L.P.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":270000.0,"shares_display":"270,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4590000.0,"total_display":"4,590,000.00","total_whole":"4,590,000","shares_owned_after":2038208.0,"shares_owned_after_display":"2,038,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":8227090,"accession":"0001209191-15-075196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-075196","line_url":"/filing/0001209191-15-075196#line-2","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Sofinnova Management VIII, L.L.C.; Sofinnova Venture Partners VIII, L.P.; POWELL MICHAEL; AKKARAJU SRINIVAS; HEALY JAMES","owner_display_name":"Sofinnova Management VIII, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":409090.0,"shares_display":"409,090","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":4499990.0,"total_display":"4,499,990.00","total_whole":"4,499,990","shares_owned_after":2289480.0,"shares_owned_after_display":"2,289,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-13","filed_date":"2015-10-13","scope":"insider"},{"id":8810155,"accession":"0001144204-15-058275","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-15-058275","line_url":"/filing/0001144204-15-058275#line-4","is_derivative":false,"issuer_cik":"0001245624","issuer_name":"Mirna Therapeutics, Inc.","issuer_ticker":"MIRN","issuer_name_source":null,"issuer_url":"/issuer/0001245624","owner_cik":null,"owner_name":"HEALY JAMES; Sofinnova Management VIII, L.L.C.; Mehra Anand; Sofinnova Venture Partners VIII, L.P.; AKKARAJU SRINIVAS","owner_display_name":"HEALY JAMES","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":857142.0,"shares_display":"857,142","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":2974811.0,"shares_owned_after_display":"2,974,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-06","filed_date":"2015-10-06","scope":"insider"},{"id":7017674,"accession":"0001144204-14-073112","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-14-073112","line_url":"/filing/0001144204-14-073112#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"HISTOGENICS CORP","issuer_ticker":"HSGX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; HEALY JAMES; Mehra Anand; AKKARAJU SRINIVAS; Sofinnova Venture Partners VIII, L.P.; Sofinnova Management VIII, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1002.0,"shares_display":"1,002","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":11022.0,"total_display":"11,022.00","total_whole":"11,022","shares_owned_after":1585650.0,"shares_owned_after_display":"1,585,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-10","scope":"insider"},{"id":7017671,"accession":"0001144204-14-073112","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-073112","line_url":"/filing/0001144204-14-073112#line-4","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"HISTOGENICS CORP","issuer_ticker":"HSGX","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"POWELL MICHAEL; HEALY JAMES; Mehra Anand; AKKARAJU SRINIVAS; Sofinnova Venture Partners VIII, L.P.; Sofinnova Management VIII, L.L.C.","owner_display_name":"POWELL MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500198.0,"shares_display":"500,198","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":5502178.0,"total_display":"5,502,178.00","total_whole":"5,502,178","shares_owned_after":2085848.0,"shares_owned_after_display":"2,085,848","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-10","scope":"insider"},{"id":6781444,"accession":"0001181431-14-014394","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-014394","line_url":"/filing/0001181431-14-014394#line-5","is_derivative":false,"issuer_cik":"0001202793","issuer_name":"Versartis, Inc.","issuer_ticker":"VSAR","issuer_name_source":null,"issuer_url":"/issuer/0001202793","owner_cik":null,"owner_name":"Mehra Anand; AKKARAJU SRINIVAS; HEALY JAMES; POWELL MICHAEL; Sofinnova Management VIII, L.L.C.; Sofinnova Venture Partners VIII, L.P.","owner_display_name":"Mehra Anand","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":1260000.0,"total_display":"1,260,000.00","total_whole":"1,260,000","shares_owned_after":2146978.0,"shares_owned_after_display":"2,146,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-26","filed_date":"2014-03-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Ten percent owner","n_filings":1,"first_seen":"2018-09-20","last_seen":"2018-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-13","last_seen":"2015-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001527599","name":"Mirna Therapeutics, Inc.","url":"/issuer/0001527599","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-06","last_seen":"2015-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001372299","name":"HISTOGENICS CORP","url":"/issuer/0001372299","role":"Ten percent owner","n_filings":1,"first_seen":"2014-12-10","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Versartis, Inc.","url":"/issuer/0001513818","role":"Ten percent owner","n_filings":1,"first_seen":"2014-03-28","last_seen":"2014-03-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559565","retrieved_at":"2026-08-22T17:14:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}